Non-viable lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans

Nutrients

Volumn 5, Issue 8, 2013, Pages 3062-3073

  Mehling, Heidrun ^a   Busjahn, Andreas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HealthTwist GmbH   (Germany)

Author keywords

Helicobacter pylori; Lactobacillus reuteri; Urea breath test

Indexed keywords

CARBON 13; PLACEBO; PROBIOTIC AGENT; PYLOPASS; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FREEZE DRYING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PILOT STUDY; SPRAY DRYING; UREA BREATH TEST;

HELICOBACTER PYLORI; LACTOBACILLUS REUTERI;

EID: 84883228427     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5083062     Document Type: Article

References (31)

1. The Helicobacter Foundation. Epidemiology. Available online: http://www.helico.com/?q=Epidemiology (accessed on 1 March 2013).
2. Blaser, M.J. Helicobacters are indigenous to the human stomach: Duodenal ulceration is due to changes in gastric microecology in the modern era. Gut 1998, 43,721-727.
3. Ford, A.C.; Axon, A.T. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2010, 15, 1-6.
4. Felley, C.; Michetti, P. Probiotics and Helicobacter pylori. Best Pract. Res. Clin. Gastroenterol. 2003, 17, 785-791.
5. Chen, Y.; Segers, S.; Blaser, M.J. Association between Helicobacter pylori and mortality in the NHANES III study. Gut 2013, in press.
6. Malfertheiner, P.; Megraud, F.; O'Morain, C.A.; Atherton, J.; Axon, A.T.; Bazzoli, F.; Gensini, G.F.; Gisbert, J.P.; Graham, D.Y.; Rokkas, T.; et al. Management of Helicobacter pylori infection-The Maastricht IV/Florence Consensus Report. Gut 2012, 61, 646-664.
7. Ramakrishna, B.S. Helicobacter pylori infection in India: The case against eradication. Indian J. Gastroenterol. 2006, 25, 25-28.
8. O'Connor, A.; Gisbert, J.P.; McNamara, D.; O'Morain, C. Treatment of Helicobacter pylori infection 2010. Helicobacter 2010, 15, 46-52.
9. Ritchie, M.L.; Romanuk, T.N. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012, 7, e34938.
10. Adams, C.A. The probiotic paradox: Live and dead cells are biological response modifiers. Nutr. Res. Rev. 2010, 23, 37-46.
11. Busjahn, A.; Lang, C. Significant reduction in Helicobacter pylori load in humans with Lactobacillus reuteri DSMZ 17648. 2010, unpublished work.
12. Saulnier, D.M.; Santos, F.; Roos, S.; Mistretta, T.A.; Spinler, J.K.; Molenaar, D.; Teusink, B.; Versalovic, J. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One 2011, 6, e18783.
13. Francavilla, R.; Lionetti, E.; Castellaneta, S.P.; Magistà, A.M.; Maurogiovanni, G.; Bucci, N.; de Canio, A.; Indrio, F.; Cavallo, L.; Ierardi, E.; Miniello, V.L. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: A pilot study. Helicobacter 2008, 13, 127-134.
14. Calvet, X.; Lehours, P.; Lario, S.; Mégraud, F. Diagnosis of Helicobacter pylori infection. Helicobacter 2010, 15, 7-13.
15. Labenz, J.; Stolte, M.; Aygen, M.; Hennemann, O.; Bertrams, J.; Borsch, G. Qualitative und semiquantitative invasive and noninvasive diagnosis of Helicobacter pylori colonization of gastric mucosa (in German). Z. Gastroenterol. 1993, 31, 437-443.
16. Zagari, R.M.; Pozzato, P.; Martuzzi, C.; Fuccio, L.; Martinelli, G.; Roda, E.; Bazzoli, F. 13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter 2005, 10, 615-619.
17. Gatta, L.; Ricci, C.; Tampieri, A.; Osborn, J.; Pema, F.; Bernabucci, V.; Vaira, D. Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: A randomised controlled trial. Gut 2006, 55, 457-462.
18. R Development Core Team. R: A Language and Environment for Statistical Computing. Available online: http://www.r-project.org/ (accessed on 28 March 2013).
19. Go, M.F. Review article: Natural history and epidemiology of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2002, 16, 3-15.
20. Konturek, P.C.; Brzozowski, T.; Konturek, S.J. Stress and the gut: Pathophysiology; clinical consequences; diagnostic approach and treatment options. J. Physiol. Pharmacol. 2011, 62, 591-599.
21. Food and Agriculture Organization of the United Nations. Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Available online: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.p df (accessed on 19 March 2013).
22. Medeiros, J.A.; Gonçalves, T.M.; Boyanova, L.; Pereira, M.I.; de Carvalho, J.N.; Pereira, A.M.; Cabrita, A.M. Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30, 555-559.
23. Cats, A.; Kuipers, E.J.; Bosschaert, M.A.; Pot, R.G.; Vandenbroucke-Grauls, C.M.; Kusters, J.G. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment. Pharmacol. Ther. 2003, 17, 429-435.
24. Linsalata, M.; Russo, F.; Berloco, P.; Caruso, M.L.; Matteo, G.D.; Cifone, M.G.; Simone, C.D.; Ierardi, E.; di Leo, A. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004, 9, 165-172.
25. Michetti, P.; Dorta, G.; Wiesel, P.H.; Brassart, D.; Verdu, E.; Herranz, M.; Felley, C.; Porta, N.; Rouvet, M.; Blum, A.L.; Corthésy-Theulaz, I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999, 60, 203-209.
26. García, C.A.; Henríquez, A.P.; Retamal, R.C.; Pineda, C.S.; Delgado Sen, C.; González, C.C. Probiotic properties of Lactobacillus spp isolated from gastric biopsies of Helicobacter pylori infected and noninfected individuals. Rev. Med. Chil. 2009, 137, 369-376.
27. Lesbros-Pantoflickova, D.; Corthésy-Theulaz, I.; Blum, A.L. Helicobacter pylori and probiotics. J. Nutr. 2007, 137, S812-S818.
28. Gotteland, M.; Brunser, O.; Cruchet, S. Systematic review: Are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment. Pharmacol. Ther. 2006, 23, 1077-1086.
29. Lang, C. DSMZ17648 specifically co-aggregates H. pylori under in vitro conditions. 2011, unpublished work.
30. Mukai, T.; Asasaka, T.; Sato, E.; Mori, K.; Matsumoto, M.; Ohori, H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol. Med. Microbiol. 2002, 32, 105-110.
31. Epple, H.J.; Kirstein, F.W.; Bojarski, C.; Frege, J.; Fromm, M.; Riecken, E.O.; Schulzke, J.D. 13C-urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of 'false' results, and influence of food intake. Scand. J. Gastroenterol. 1997, 32, 308-314.